People: Safeguard Scientifics Inc (SFE)
SFE on New York Consolidated
15.82USD
23 May 2013
15.82USD
23 May 2013
Price Change (% chg)
$-0.10 (-0.63%)
$-0.10 (-0.63%)
Prev Close
$15.92
$15.92
Open
$15.81
$15.81
Day's High
$15.97
$15.97
Day's Low
$15.70
$15.70
Volume
8,176
8,176
Avg. Vol
72,767
72,767
52-wk High
$18.00
$18.00
52-wk Low
$13.15
$13.15
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Andrew Lietz |
73 | 2009 | Independent Chairman of the Board |
Stephen Zarrilli |
51 | 2013 | President, Chief Executive Officer, Director |
Jeffrey McGroarty |
43 | 2013 | Chief Financial Officer, Senior Vice President - Finance |
Timothy Levy |
29 | Corporate Counsel | |
James Datin |
50 | 2005 | Executive Vice President, Managing Director |
Brian Sisko |
52 | 2012 | Executive Vice President, Managing Director |
Steven Grenfell |
Vice President - Operations | ||
Mark Mitchell |
2005 | Principal | |
Jim O'Connell |
Principal | ||
Gary Kurtzman |
57 | Managing Director | |
Erik Rasmussen |
2006 | Managing Director | |
Heather Hunter |
Director of Marketing Communications | ||
Pitamber Devgon |
Senior Associate | ||
Kartheek Mulpuri |
Associate | ||
Daniel Van den Bergh |
Associate | ||
Andrew Murphy |
Assistant Controller | ||
Peter Boni |
2012 | Director | |
Keith Jarrett |
57 | 2012 | Director |
Julie Dobson |
56 | 2003 | Independent Director |
George MacKenzie |
64 | 2003 | Independent Director |
George McClelland |
65 | 2006 | Independent Director |
Jack Messman |
73 | 1994 | Independent Director |
John Roberts |
67 | 2003 | Independent Director |
Robert Rosenthal |
55 | 2007 | Independent Director |
John Shave |
Vice President - Business Development and Corporate Communications |
Biographies
| Name | Description |
|---|---|
Andrew Lietz |
Mr. Andrew E. Lietz is Independent Chairman of the Board of Safeguard Scientifics Inc. He has served on Board since 2003 and was appointed Chairman of the Board in August 2009. Mr. Lietz also is a director of Amphenol Corporation and DDi Corp. and previously served as a director of Omtool Corporation. Positions held include Managing Director and Founder of Rye Capital Management, LLC, a private equity investment firm (2001 to 2008); Executive Chairman (late 2000 until mid-2002) of Clare Corporation, a designer and manufacturer of integrated circuits, solid-state relays and electronic switches, which was acquired by Ixys Corporation in June 2002; President and Chief Executive Officer (1995 to 2000) of, and several other executive positions during his 16-year career with, Hadco Corporation, a global manufacturer of electronic interconnect products and services; and a variety of positions at IBM Corporation. Mr. Lietz holds a BS degree from the Wayne State University Business Administration School. |
Stephen Zarrilli |
Mr. Stephen T. Zarrilli is President, Chief Executive Officer, Director of Safeguard Scientfics, Inc. Mr. Zarrilli joined Safeguard as Senior Vice President and Chief Financial Officer in June 2008 and became President and Chief Executive Officer in November 2012. Prior to joining Safeguard, Mr. Zarrilli co-founded, in 2004, the Penn Valley Group, a middle-market management advisory and private equity firm, and served as a Managing Director there until June 2008. He continues to serve as non-executive chairman of the Penn Valley Group. Mr. Zarrilli also served as Acting Senior Vice President, Acting Chief Administrative Officer and Acting Chief Financial Officer of Safeguard from December 2006 to June 2007. Mr. Zarrilli also served as the Chief Financial Officer, from 2001 to 2004, of Fiberlink Communications Corporation, a provider of remote access VPN solutions for enterprises; as the Chief Executive Officer, from 2000 to 2001, of Concellera Software, Inc., a developer of content management software; as the Chief Executive Officer, from 1999 to 2000, and Chief Financial Officer, from 1994 to 1998, of US Interactive, Inc. (at the time a public company), a provider of Internet strategy consulting, marketing and technology services (US Interactive filed for bankruptcy protection under Chapter 11 of the United States Bankruptcy Code in January 2001); and, previously, with Deloitte & Touche from 1983 to 1994. Mr. Zarrilli is a director and Chairman of the Audit Committee of NutriSystem, Inc. |
Jeffrey McGroarty |
Mr. Jeffrey B. McGroarty, CPA, is Chief Financial Officer, Senior Vice President - Finance of Safeguard Scientifics Inc. Mr. McGroarty joined Safeguard as Vice President and Corporate Controller in December 2005, subsequently became Vice President – Finance and Corporate Controller, and has served as Senior Vice President – Finance since November 2012. Prior to joining Safeguard, Mr. McGroarty served as Interim Controller of Cephalon, Inc. from October 2005 to December 2005; Vice President-Financial Planning & Analysis and previously Assistant Controller at Exide Technologies from March 2002 to September 2005; and, previously, with PricewaterhouseCoopers from 1991 to 2001. |
Timothy Levy |
Mr. Timothy J. Levy is Corporate Counsel at Safeguard Scientifics Inc. Before that, he was an associate in the Reston, Virginia office of Cooley LLP, where his practice consisted of general business and corporate law matters, with an emphasis on representing emerging growth life sciences and technology companies and their investors. Previously, he was an associate at Shaw Pittman LLP in Tysons Corner, VA and Arent Fox PLLC in Washington, DC. Previously, he co-founded VarsityBooks.com Inc., an online supplier of textbooks to college and high school students. In 2003, he co-founded The K-12 Group Inc. a provider of products and services to parents, students and teachers in grades K-12, that was acquired by School Tool BoxTM, which offers convenient, affordable supplies to PTA/PTOs and school districts alike in hundreds of school districts across the country. He graduated from Columbia University with a B.A. in English and received his J.D. with honors from The George Washington University Law School, where he was a member of The George Washington Journal of International Law and Economics. Following law school, Tim served as a law clerk to the Hon. William A. Dreier, Presiding Judge of the Appellate Division, Superior Court of New Jersey. |
James Datin |
Mr. James A. Datin is Executive Vice President, Managing Director of Safeguard Scientifics, Inc., since September 2005. Mr. Datin served as Chief Executive Officer of Touchpoint Solutions, Inc., a provider of software that enables customers to develop and deploy applications, content and media on multi-user interactive devices, from December 2004 to June 2005; Group President in 2004, and as Group President, International, from 2001 to 2003, of Dendrite International, a provider of sales, marketing, clinical and compliance solutions and services to global pharmaceutical and other life sciences companies; and Group Director, Corporate Business Strategy and Planning at GlaxoSmithKline, from 1999 to 2001, where he also was a member of the company’s Predictive Medicine Board of Directors that evaluated acquisitions and alliances. His prior experience also includes international assignments with and identifying strategic growth opportunities for E Merck and Baxter. Mr. Datin is a director of NuPathe, Inc. |
Brian Sisko |
Mr. Brian J. Sisko is Executive Vice President, Managing Director of Safeguard Scientifics, Inc. Mr. Sisko joined Safeguard as Senior Vice President and General Counsel in August 2007 and became Executive Vice President and Managing Director in November 2012. Prior to joining Safeguard, Mr. Sisko served as Chief Legal Officer, Senior Vice President and General Counsel of Traffic.com (at the time, a public company), a former partner company of Safeguard, from February 2006 until June 2007 (following its acquisition by NAVTEQ Corporation in March 2007); Chief Operating Officer from February 2005 to January 2006 of Halo Technology Holdings, Inc., a public holding company for enterprise software businesses (Halo Technology Holdings filed for bankruptcy protection under Chapter 11 of the United States Bankruptcy Code in August 2007); ran B/T Business and Technology, an advisor and strategic management consultant to a variety of public and private companies, from January 2002 to February 2005; and was a Managing Director from April 2000 to January 2002, of Katalyst, LLC, a venture capital and consulting firm. Mr. Sisko also previously served as Senior Vice President—Corporate Development and General Counsel of National Media Corporation, at the time a New York Stock Exchange-listed multi-media marketing company with operations in 70 countries, and as a partner in the corporate finance, mergers and acquisitions practice group of the Philadelphia-based law firm, Klehr, Harrison, Harvey, Branzburg & Ellers LLP. Mr. Sisko is a director of NuPathe, Inc. |
Steven Grenfell |
Mr. Steven J. Grenfell, CPA is Vice President of Operations at Safeguard Scientifics Inc. Before that, he provided financial and operational leadership as Chief Financial Officer of Safeguard’s former partner company, RealTIME Media, where he changed the business model from an Internet promotions application services provider to an Internet promotions agency. Previously, he was Executive Director of Clinical Development and Medical Affairs at AstraZeneca (NYSE: AZN) where he actively participated in all aspects of financial, clinical trial cost management, licensing, organizational structure and administrative matters for the U.S. clinical development team. He also held several financial and operational positions with a pharmaceutical joint venture firm, a public oil and gas provider, and a privately held manufacturer and refurbisher of pay telephones. Earlier in his career, he was Audit Manager at Price Waterhouse, now PricewaterhouseCoopers LLP, working with clients in various industries in both mid-market businesses and general audit. He earned his B.A. in accounting from King’s College. |
Mark Mitchell |
Mr. Mark A. Mitchell is Principal, Technology at Safeguard Scientifics Inc. Before that, he helped build Wachovia Securities’ East Coast Technology group, where he focused on M&A and IPO transactions for Internet & software companies. He also previously worked at Broadview International, providing M&A advisory services to companies in the Internet, software and communications infrastructure markets. Earlier in his career, he served as a consultant at PTG, a strategy and growth management consultancy, where he provided strategic advice to both Fortune 500 and early-stage technology companies. He holds B.A. degrees in Physics and Philosophy from Duke University, and received an M.B.A. from The Wharton School at the University of Pennsylvania. |
Jim O'Connell |
Mr. Jim P. O'Connell is Principal and Kauffman Fellow, Life Sciences at Safeguard Scientifics Inc. Before that, he served as Summer Associate for Quaker BioVentures and Commons Capital, and also completed an internship at Liquidia Technologies in business development. Prior, he was in the Corporate Ventures/Business Development group of Becton Dickinson, a F500 medical technology firm. From 1998 toi 2001, he held progressive positions in Sales, Marketing and Business Development at Chemdex. He received a B.S. in biochemistry from Virginia Tech and served as class president for four years. Jim also received an M.B.A. from The Wharton School at the University of Pennsylvania. |
Gary Kurtzman |
Dr. Gary J. Kurtzman, M.D. is Managing Director at Safeguard Scientifics Inc. He joined the Firm from BioAdvance, a state initiative committed to funding early-stage life sciences companies, where he served as Managing Director and Chief Operating Officer. Previously, he was Chief Executive Officer at Pluvita Corporation, a company developing biological and bioinformatic solutions for drug and diagnostic development. He also previously served as Chief Operating Officer at Genovo, Inc., a gene therapy start-up company. He was also employed as head of research & development by Avigen, Inc., an early-stage gene therapy company located in San Francisco. He began his career with Gilead Sciences, Inc.—at the time, a pre-IPO biotechnology company—as virology group leader. Presently, he serves on various academic and biomedical committees and boards along with the editorial board of Biotechnology Healthcare. Presently, he is a lecturer in the Health Care Systems Department at the Wharton School at the University of Pennsylvania where he teaches entrepreneurship in life sciences. |
Erik Rasmussen |
Mr. Erik B. Rasmussen is Managing Director, Technology at Safeguard Scientifics Inc. Before that, he was a partner at WWC Capital Group, LLC, an investment banking and venture capital firm. He WWC from The Aurora Funds, a venture capital fund based in Durham, NC. He managed Aurora’s Washington, DC office, focusing on Internet, software, and wireless investments. He was a Business Development manager for RISCManagement, a network and systems integrator whose customers included Fortune 500 companies. Prior to joining RISCManagement, Erik was a Product Manager for a line of TCP/IP products at Beame & Whiteside Software, Inc., a private networking software company that was acquired by Hummingbird Communications, Ltd. He currently serves on the Steering Committee for the Mid-Atlantic Venture Association (MAVA) and was a Co-Chair for MAVA’s Capital Connection Venture Conference in 2009. He earned a BA degree in Economics from Lake Forest College and an MBA from Boston College’s Carroll School of Management. |
Heather Hunter |
Ms. Heather R. Hunter is Director, Marketing Communications at Safeguard Scientifics Inc. Before that, she was Vice President of Corporate Communications at W. P. Carey & Co. LLC. She is a member of the Strategic Communications Group at the National Venture Capital Association (NVCA); the Communications Committee at Pennsylvania Bio; and is active with The Network For Teaching Entrepreneurship (NFTE), Public Relations Society of America (PRSA) and the Alumni Schools Committee at Yale University. She graduated from Yale with a B.A. in History. |
Pitamber Devgon |
Dr. Pitamber Devgon, M.D. is Senior Associate at Safeguard Scientifics Inc. Before that, he was a summer associate at Medtronic in their Neuromodulation business prior to starting his second year at Wharton. During his residency training, he also completed internships in technology transfer at Penn’s CTT office and healthcare venture capital at Safeguard Scientifics. In 2009, he was part of the grand prize winning team, NIR Diagnostics, in the Wharton Business Plan Competition and served as CMO. Prior to his medical training and residency, he founded and directed the first online student portal website called the Student Information Network, which became Sinapse Consulting with branch offices in the Midwest and Washington, DC. He holds a B.A. in biological psychology from the College of William & Mary, an M.D. with honors from Eastern Virginia Medical School (EVMS) and an M.B.A. from The Wharton School at the University of Pennsylvania. |
Kartheek Mulpuri |
Mr. Kartheek Mulpuri is Associate, Technology at Safeguard Scientifics Inc. Before that, he was a technology investment banker at Jefferies’ Foster City, CA office. He also interned at Booz Allen Hamilton and Goldman Sachs. He graduated from Stanford University with a M.S. in Management Science & Engineering and from Cornell University with a B.S. in Operations Research & Information Engineering where he was a Hunter R. Rawlings III Cornell Presidential Research Scholar. |
Daniel Van den Bergh |
Mr. Daniel P. Van den Bergh is Associate, Life Sciences at Safeguard Scientifics Inc. Before that, he was a healthcare investment banker at EuroConsult Capital's New York office and Citigroup's London and New York offices. He graduated from Cornell University with a B.S. in Biological Engineering and Applied Economics where he worked at the Walker Lab on novel ways to monitor biofuel production using nanotechnology. |
Andrew Murphy |
Mr. Andrew C. Murphy, CPA is Assistant Controller at Safeguard Scientifics Inc. Before that, he spent 12 years in public accounting focused on financial audits and SEC reporting. He was an audit Senior Manager with PricewaterhouseCoopers LLP in Philadelphia, PA serving primarily multinational public companies in the manufacturing, medical products, chemical and pharmaceutical industries. In addition, he provided service to non-public companies in the auto dealership, retail/distributor, not for profit and government industries. He also served as a Senior Manager in PricewaterhouseCoopers' National Professional Services Group in Florham Park, NJ where he specialized in Accounting Consulting Services (ACS). In ACS, Drew assisted client engagement teams across the country in solving complex technical accounting issues primarily concerning revenue recognition, loss contingencies, inventory and stock compensation. |
Peter Boni |
Mr. Peter J. Boni is no longer Director, effective May 23, 2013 and is no longer President, Chief Executive Officer, effective November 1, 2012 of Safeguard Scientifics Inc. Mr. Boni previously served as a director of Clarient, Inc. and was previously non-executive Chairman of Intralinks, Inc. Positions held include Operating Partner for Advent International, Inc; Chairman and Chief Executive Officer of Surebridge, Inc., an applications outsourcer serving the mid-market (March 2002 to April 2004); Managing Principal of Vested Interest LLC, a management consulting firm (January 2001 to March 2002); and President and Chief Executive Officer of Prime Response, Inc., an enterprise applications software provider (February 1999 to January 2001). Mr. Boni holds a BA degree from the University of Massachusetts at Amherst. |
Keith Jarrett |
Dr. Keith B. Jarrett has been appointed as Director of Safeguard Scientifics, Inc., effective May 25, 2012. Dr. Jarrett has more than 25 years of experience in venture capital, private equity and finance technology, driving value for customers, shareholders, investors and employees. Since 2002, Dr. Jarrett has served as a private investor and active board representative to venture stage and other private growth equity organizations, as well as a corporate advisor providing strategic, organizational development and capital market advisory for selected organizations and private equity firms, with a focus in the financial and medical information technology sectors. Dr. Jarrett is a principal of Rockport Funding, LLC, a specialty finance start-up company incubator and private equity investment boutique which he co-founded in 2003, and serves on the Board of Trustees for the Raymond James Financial Eagle Funds. From 1986-2001, Keith was a founding executive of Thomson Financial, a vendor of information and technology solutions to the global financial community. During this time, Keith served as the CEO of Thomson Financial International for seven years, founded and directed Thomson Financial's Corporate Venture Capital Group, and founded and developed many of the products and services for Thomson Financial's Straight Through Processing ("STP") initiatives, including the Thomson Electronic Settlement Group (now "Omgeo") and AutEx TradeRoute. Keith joined Thomson Financial in 1986, with the acquisition of First Call/Technical Data Corporation, where he was a Principal and Chief Economist. Keith has an M.B.A. from the University of Massachusetts, Amherst and a Ph.D. in Financial Economics from Harvard Business School. He worked as a Research Associate at the Harvard Business School and as a Professor at Simmons College Graduate Management Program. Previously, Keith served as a Captain in the U.S. Army after graduating with honors from the United States Military Academy at West Point. |
Julie Dobson |
Ms. Julie A. Dobson is Independent Director of Safeguard Scientifics Inc. Ms. Dobson also is a director of American Water Works Company, Inc. and PNM Resources, Inc. and previously served as non-executive Chairperson of the Board of LCC International, Inc. Positions held include Chief Operating Officer (1998 until February 2002) of TeleCorp PCS, Inc., a wireless/mobile phone company that was acquired by AT&T Wireless, Inc. in late 2001; President of Bell Atlantic Corporation’s New York/ New Jersey Metro Region mobile phone operations (1997 to 1998); and a number of executive positions during her 18-year career with Bell Atlantic Corporation, including sales, operations, and strategic planning and development in the chief executive officer’s office. Ms. Dobson holds a BS degree from The College of William and Mary and an MBA degree from the University of Pittsburgh. Ms. Dobson has 22 years of corporate and entrepreneurial experience, including experience relevant to corporate finance and accounting matters; strategic planning, corporate development and operations management; capital markets transactions; and debt and equity financings. |
George MacKenzie |
Mr. George MacKenzie is Independent Director of Safeguard Scientifics Inc. Mr. MacKenzie also is a director of American Water Works Company, Inc. and Tractor Supply Company and previously served as a director of C&D Technologies, Inc., Central Vermont Public Service Company and Traffic.com. Positions held include non-executive Chairman of the Board (May 2006 to present) and interim Chief Executive Officer (January 2006 to April 2006) of American Water, a provider of water services in North America; interim Chief Executive Officer of C&D Technologies, Inc., a technology company that produces and markets systems for the conversion and storage of electrical power (March 2005 to July 2005); Executive Vice President and Chief Financial Officer of P.H. Glatfelter Company, a manufacturer of specialty papers and engineered products (September 2001 to June 2002); Vice Chairman (2000 to 2001) and Chief Financial Officer (1995 until his retirement in 2001) of, and several other executive positions during his 22-year career with, Hercules, Incorporated, a global chemical specialties manufacturer. Mr. MacKenzie holds a BS degree from the University of Delaware and an MBA degree from the University of Chicago. Mr. MacKenzie has experience in corporate finance and accounting. He has served as the chief financial officer of a publicly traded company, and he is a certified public accountant. |
George McClelland |
Mr. George D. McClelland is Independent Director of Safeguard Scientifics Inc. Positions held include co-founder, Vice Chairman and Director of Business Development of F Squared Investments, an investment Positions held include co-founder, Vice Chairman and Director of Business Development of F Squared Investments, an investment management company (2006 to present); Chairman, CEO and co-founder of eSecLending, a provider of securities lending services to the pension industry (2000 to 2001); a director of Riverstone Networks, Inc. and Storage Networks, Inc.; Senior Vice President, responsible for managing many of the portfolio companies of United Asset Management Corporation, a public holding company (1994 to 2001); multiple corporate management roles at FMR Corp., a diversified financial services company (1987 to 1991); and Corporate Treasurer of Data General Corporation, a technology company (1972 to 1987). Mr. McClelland holds a BA degree from Trinity College and an MBA degree from Harvard Business School. Mr. McClelland has experience in corporate finance, treasury and accounting; capital markets transactions; debt and equity financings; venture investment; investment management; merger and acquisition transactions; and risk management. |
Jack Messman |
Mr. Jack L. Messman is Independent Director of Safeguard Scientifics Inc. Mr. Messman also is a director of AMG Advanced Metallurgical Group N.V., RadioShack Corporation and Timminco Limited. Positions held include Chairman of the Board and Chief Executive Officer of Novell, Inc., a provider of infrastructure software products focused around Linux and identity management (2001 to 2006); Chief Executive Officer and President of Cambridge Technology Partners (Massachusetts), Inc., an e-business systems integration company (August 1999 until its acquisition by Novell, Inc. in July 2001); Chairman and Chief Executive Officer of Union Pacific Resources Group Inc., an independent oil and gas exploration and production company (April 1991 to August 1999); and Chairman and Chief Executive Officer of USPCI, Inc., Union Pacific’s environmental services company (May 1988 to April 1991). Mr. Messman holds a BS degree from the University of Delaware and an MBA degree from Harvard Business School. |
John Roberts |
Mr. John J. Roberts is Independent Director of Safeguard Scientifics Inc. Mr. Roberts also is a director of Armstrong World Industries, Inc. and Vonage Holdings Corp. and a trustee of Pennsylvania Real Estate Investment Trust and previously served as a director of Sicor, Inc. Positions held include Global Managing Partner and a Member of the Leadership Team of PricewaterhouseCoopers LLP at the time of his retirement in June 2002, completing a 35-year career with the professional services firm during which he served in a variety of client service and operating positions. Mr. Roberts holds a BSBA degree from Drexel University and is a certified public accountant. |
Robert Rosenthal |
Dr. Robert (Bob) J. Rosenthal, Ph.D. is Independent Director of Safeguard Scientifics Inc. Dr. Rosenthal also is a director of Primera Dx. Positions held include Chairman of the Board and Chief Executive Officer of IMI Intelligent Medical Implants AG, a company that is developing an intelligent retinal implant system for degenerative retinal disorders (January 2010 to present); President, Chief Executive Officer and a director of Magellan Biosciences, Inc., a provider of clinical diagnostics and life sciences research tools (October 2005 to December 2009); President, Chief Executive Officer and a director of TekCel, Ltd., a provider of life sciences research tools (October 2003 to January 2007); President and Chief Executive Officer of Boston Life Sciences, Inc., a diagnostic and therapeutic development company (July 2002 to October 2003); President and Chief Executive Officer of Magellan Discovery Technologies, LLC, a life sciences acquisition company (January 2001 to July 2002); Senior Vice President of PerkinElmer Corporation and President of its instrument division (March 1999 to November 2000); and in various executive positions at Thermo Optek Corporation (September 1995 to February 1999). Dr. Rosenthal holds a BS degree from the University of Maryland, an MS degree from State University of New York, and a PhD degree from Emory University; completed a post-doctoral fellowship at, and was a guest scientist of the Alexander von Humboldt Foundation, followed by an additional post-doctoral fellowship at UCLA; and he holds an AEA Executive MBA degree from Stanford University. |
John Shave |
Mr. John E. Shave III is Vice President, Business Development and Corporate Communications at Safeguard Scientifics Inc. Before that, he was Vice President of Investor Relations at The Reynolds and Reynolds Company. Previously, he was Co-Founder and Managing Partner of U.S. operations for National Public Relations, Inc. Before National Public Relations, he was an investor relations and corporate communications account executive for Thomson Financial / Georgeson & Company, and Robert Marston Corporate Communications, both based in New York City, where he advised clients in investor relations, corporate governance, M&A and corporate control transactions. He earned a B.A. from Susquehanna University where he was named the Department of Communications Most Outstanding Student for 1992-1993 and is a graduate from the Stanford University Executive Institute. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Andrew Lietz |
-- |
Stephen Zarrilli |
1,049,710 |
Jeffrey McGroarty |
-- |
Timothy Levy |
-- |
James Datin |
1,113,000 |
Brian Sisko |
849,671 |
Steven Grenfell |
-- |
Mark Mitchell |
-- |
Jim O'Connell |
-- |
Gary Kurtzman |
-- |
Erik Rasmussen |
-- |
Heather Hunter |
-- |
Pitamber Devgon |
-- |
Kartheek Mulpuri |
-- |
Daniel Van den Bergh |
-- |
Andrew Murphy |
-- |
Peter Boni |
1,909,790 |
Keith Jarrett |
-- |
Julie Dobson |
-- |
George MacKenzie |
-- |
George McClelland |
-- |
Jack Messman |
-- |
John Roberts |
-- |
Robert Rosenthal |
-- |
John Shave |
-- |
As Of 30 Dec 2011
Options Compensation
| Name | Options | Value |
|---|---|---|
Andrew Lietz |
0 | 0 |
Stephen Zarrilli |
0 | 0 |
Jeffrey McGroarty |
0 | 0 |
Timothy Levy |
0 | 0 |
James Datin |
2,000,000 | 740,000 |
Brian Sisko |
0 | 0 |
Steven Grenfell |
0 | 0 |
Mark Mitchell |
0 | 0 |
Jim O'Connell |
0 | 0 |
Gary Kurtzman |
0 | 0 |
Erik Rasmussen |
0 | 0 |
Heather Hunter |
0 | 0 |
Pitamber Devgon |
0 | 0 |
Kartheek Mulpuri |
0 | 0 |
Daniel Van den Bergh |
0 | 0 |
Andrew Murphy |
0 | 0 |
Peter Boni |
4,000,000 | 2,620,000 |
Keith Jarrett |
0 | 0 |
Julie Dobson |
0 | 0 |
George MacKenzie |
0 | 0 |
George McClelland |
0 | 0 |
Jack Messman |
0 | 0 |
John Roberts |
0 | 0 |
Robert Rosenthal |
0 | 0 |
John Shave |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
MACKENZIE GEORGE JR |
2,245 | $14.20 |
MACKENZIE GEORGE JR |
2,500 | $12.75 |
ROBERTS JOHN JOSEPH |
4,400 | $0.00 |
ZARRILLI STEPHEN T |
9,906 | $0.00 |
MCGROARTY JEFFREY B |
900 | $0.00 |
SISKO BRIAN J |
405 | $0.00 |
ROBERTS JOHN JOSEPH |
4,166 | $11.46 |
ROBERTS JOHN JOSEPH |
4,166 | $7.14 |
ROBERTS JOHN JOSEPH |
3,283 | $13.88 |
ROBERTS JOHN JOSEPH |
4,429 | $13.88 |
ROBERTS JOHN JOSEPH |
4,166 | $10.94 |
ROBERTS JOHN JOSEPH |
2,297 | $13.88 |
ROBERTS JOHN JOSEPH |
5,000 | $12.29 |
ROBERTS JOHN JOSEPH |
3,439 | $13.88 |
ROBERTS JOHN JOSEPH |
2,144 | $13.88 |
ROBERTS JOHN JOSEPH |
2,500 | $12.75 |
ZARRILLI STEPHEN T |
1,300 | $14.31 |
ZARRILLI STEPHEN T |
500 | $14.15 |
DATIN JAMES A |
1,787 | $14.09 |
SISKO BRIAN J |
1,836 | $0.00 |
BONI PETER J |
5,109 | $0.00 |
ZARRILLI STEPHEN T |
2,395 | $0.00 |
DATIN JAMES A |
2,395 | $0.00 |
MESSMAN JACK L |
2,500 | $15.96 |
MESSMAN JACK L |
2,500 | $12.75 |

